These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Nephrogenic systemic fibrosis, in patients with end-stage kidney disease on dialysis, in the greater Auckland region, from 2000-2006. Kendrick-Jones JC, Voss DM, De Zoysa JR. Nephrology (Carlton); 2011 Feb; 16(2):243-8. PubMed ID: 21272139 [Abstract] [Full Text] [Related]
16. The evolution of osseous metaplasia in localized cutaneous nephrogenic systemic fibrosis: a case report. Wiedemeyer K, Kutzner H, Abraham JL, Thakral C, Carlson JA, Tran TA, Hausser I, Hartschuh W. Am J Dermatopathol; 2009 Oct; 31(7):674-81. PubMed ID: 19633532 [Abstract] [Full Text] [Related]
17. [Nephrogenic systemic fibrosis]. Cavallini L, Abaterusso C, Bedogna V, Pertica N, Loschiavo C, Lupo A. G Ital Nefrol; 2008 Oct; 25(1):14-20. PubMed ID: 18264914 [Abstract] [Full Text] [Related]
18. Patient characteristics and risk factors for nephrogenic systemic fibrosis following gadolinium exposure. Grobner T, Prischl FC. Semin Dial; 2008 Oct; 21(2):135-9. PubMed ID: 18226001 [Abstract] [Full Text] [Related]
19. Nephrogenic systemic fibrosis associated with gadolinium based contrast agents: a summary of the medical literature reporting. Broome DR. Eur J Radiol; 2008 May; 66(2):230-4. PubMed ID: 18372138 [Abstract] [Full Text] [Related]
20. Removal of gadolinium by dialysis: review of different strategies and techniques. Silberzweig JI, Chung M. J Magn Reson Imaging; 2009 Dec; 30(6):1347-9. PubMed ID: 19937933 [Abstract] [Full Text] [Related] Page: [Next] [New Search]